EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease

Andrea Pretta, Pina Ziranu, Francesca Bergamo, Andrea Bottelli, Federica Marmorino, Mariapaola Masiello, Stefano Mariani, Krisida Cerma, Filippo Ghelardi, Paolo Ciracì, Alessia Lancianese, Valeria Pusceddu und 15 weitere

Clinical Colorectal Cancer · 2026

DOI: 10.1016/j.clcc.2026.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2026. Verfasst von Andrea Pretta und 26 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. Electronic address: an.pretta@gmail.com. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Metastasectomy, Hepatectomy. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent studies have shown an increased incidence of early-onset CRC (EO-CRC), particularly in advanced stages and with metastatic disease. Our study aimed to evaluate the role of metastasectomies related to the clinical and molecular characteristics of EO-CRC patients with liver metastases compared to average-onset CRC (AO-CRC) patients. METHODS: We retrospectively collected data from 1123 stage IV colorectal cancers, including 782 with liver metastases, from 5 different Italian institutions. The main objective of the study was to compare the overall survival of liver metastatic EO-CRC and AO-CRC patients who underwent metastasectomy versus those who were not resected. RESULTS: Liver resected EO-CRCs patients showed a statistically significant lower mOS than liver resected AO-CRCs (44.0 vs. 64.0 months, P < .0001). mPFS was also statistically significant lower in EO-CRCs (13.0 vs. 17.0, P < .0001). Same outcomes were found in RAS mut subgroup (37.0 vs. 52.0 months, P < .0001) and in RAS/BRAF wild-type subgroup (50.0 vs. 81.0 months, P < .0001). EO-CRC patients showed a higher prevalence of TP53 alterations (56.2%) and a lower of APC mutation (29.9%). EO-CRCs presented a higher frequency of ARID1A (4.4%) and CTNNB1 (3.0%) alterations. CONCLUSION: The results indicate a worse overall prognosis for EO-CRC patients undergoing metastasectomy compared to average-onset patients. This outcome appears to occur independently of the molecular status. These observations could have a considerable impact on clinical practice and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsMetastasectomyHepatectomyHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAge of OnsetNeoplasm StagingAdultItalyPrognosisAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

Early-onset colorectal cancerGastrointestinal cancerLiver limited colorectal cancerLiver metastasesYoung adults cancer

Autor:innen und Institutionen

  • Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. Electronic address: an.pretta@gmail.com.
  • Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Clinical Oncology, Department of Clinical and Molecular Sciences, University Politecnica delle Marche - University Hospital "Azienda Ospedaliero Universitaria delle Marche", Ancona, Italy.

Förderung

  • European Commission
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Pretta, A., Ziranu, P., Bergamo, F., Bottelli, A., Marmorino, F., Masiello, M., Mariani, S., Cerma, K., Ghelardi, F., Ciracì, P., Lancianese, A., Pusceddu, V., Perissinotto, E., Leone, A. G., Taravella, A., Cimbro, E., Pretta, G., Cerantola, R., Papini, L., …, & Scartozzi, M. (2026). The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.02.002

Vancouver

Pretta A, Ziranu P, Bergamo F, Bottelli A, Marmorino F, Masiello M, et al. The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease. Clinical Colorectal Cancer. 2026. doi:10.1016/j.clcc.2026.02.002

BibTeX
@article{Pretta2026,
  author = {Pretta, Andrea and Ziranu, Pina and Bergamo, Francesca and Bottelli, Andrea and Marmorino, Federica and Masiello, Mariapaola and Mariani, Stefano and Cerma, Krisida and Ghelardi, Filippo and Ciracì, Paolo and Lancianese, Alessia and Pusceddu, Valeria and Perissinotto, Eleonora and Leone, Alberto Giovanni and Taravella, Ada and Cimbro, Erika and Pretta, Gianluca and Cerantola, Riccardo and Papini, Luca and Donisi, Clelia and Ricagno, Gianmarco and Squitieri, Raffaele and Giampieri, Riccardo and Cremolini, Chiara and Lonardi, Sara and Pietrantonio, Filippo and Scartozzi, Mario},
  title = {The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease},
  journal = {Clinical Colorectal Cancer},
  year = {2026},
  doi = {10.1016/j.clcc.2026.02.002}
}
Kostenlos starten →